Cargando…
The VTA dopaminergic system as diagnostic and therapeutical target for Alzheimer's disease
Neuropsychiatric symptoms (NPS) occur in nearly all patients with Alzheimer's Disease (AD). Most frequently they appear since the mild cognitive impairment (MCI) stage preceding clinical AD, and have a prognostic importance. Unfortunately, these symptoms also worsen the daily functioning of pat...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9618946/ https://www.ncbi.nlm.nih.gov/pubmed/36325523 http://dx.doi.org/10.3389/fpsyt.2022.1039725 |